Abstract
Kvalitet života pacijenata sa shizofrenijom lečenih dugodelujućim risperidonom i paliperidon-palmitatom
Highlights
In recent decades, researchers devoted a lot of attention to studying the quality of life of people with mental disorders
Светска Здравствена организација (СЗО) дефинише''квалитет живота''као „поглед појединца на сопствени статус у животу унутар културних оквира и система вредности у којем живи у поређењу са циљевима, очекивањима, стандардима и проблемима околине“1
Изгледа да социјална димензија квалитета живота схизофрених пацијената бива највише осиромашена хроничним током болести[4]
Summary
Researchers devoted a lot of attention to studying the quality of life of people with mental disorders. Improving quality of life of people with schizophrenia is becoming an obligation of pharmacological therapy. The aim: The aim of the paper was to assess certain aspects of quality of life of the patients suffering from schizophrenia treated with longacting risperidone and paliperidonе-palmitate and to determine the impact of socio-demographic characteristics on the quality of life of these patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have